Terveystalo Oyj
TTALO
ISIN FI4000252127 / Valor 37893402
Terveystalo Oyj
UMushroom community rating:
About company
Terveystalo Oyj stands as Finland's premier private healthcare service provider, distinguished by its extensive revenue and expansive network. It holds a significant position in the Nordic region as a foremost provider of occupational health services. The company's comprehensive offerings encompass a broad spectrum of primary healthcare, specialized care, and well-being services catering to a diverse clientele that includes corporate entities, private individuals, and the public sector. Terveystalo's innovative approach is further exemplified by its round-the-clock digital services, ensuring healthcare accessibility irrespective of geographical and temporal constraints. With a robust presence manifested through over 377 clinics across Finland and 152 occupational health service clinics in Sweden, Terveystalo demonstrates a commitment to healthcare excellence. The company's notable market position is underscored by its listing on the Helsinki Stock Exchange and its recognition as an attractive employer within the healthcare and pharmaceutical industry. In 2023, Terveystalo reported a revenue of EUR 1,286 million, serving approximately 1.2 million individual customers in Finland through around 7.6 million customer appointments. The organization's workforce comprises over 15,500 healthcare and well-being professionals, highlighting its substantial contribution to the healthcare sector. Additionally, Terveystalo's engagement in clinical research, through its Terveystalo Biobank and Clinical Research (TBCR) unit, emphasizes its role in advancing medical knowledge and practices.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.10.2025):
Terveystalo Oyj reported a mixed second quarter of 2025, with a slight decrease in revenue but improved profitability metrics, showcasing the company's enhanced operational efficiency despite challenging market conditions.
Revenue Decline
Revenue for Q2 2025 decreased by 5.5% year-on-year to EUR 321.5 million. The Healthcare Services segment saw a minor decline of 1.6%, while Portfolio Businesses experienced a significant decrease of 21.8%, including a 7.3% drop in revenue from Sweden.
Improved Operating Profit
Adjusted operating profit (EBIT) increased by 5.1% to EUR 36.7 million, representing 11.4% of revenue. The overall EBIT saw a substantial rise of 36.2%, reaching EUR 33.4 million.
Earnings Per Share
Earnings per share rose by 55.1%, reaching EUR 0.18 compared to EUR 0.11 in the same quarter last year.
Cash Flow and Net Result
The cash flow from operating activities was EUR 40.5 million. The net result for the period amounted to EUR 22.2 million.
Customer Satisfaction
The Net Promoter Score (NPS) remained stable, with appointments at 86.8 and hospitals at 95.4.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1476 M
Market cap (USD)
73,018
Daily traded volume (Shares)
10.48 / 10.34
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
